Skip to content
OpenCapital
Get started

GoodRx Holdings, Inc. GDRX Prescription transactions revenue — Sales and marketing

Similar metrics at other companies

AMP
AMPHPharmaceutical Products — Marketing And Advertising Expense
$3.06M-21.3%
DBV Technologies logo
DBVTExpenses by function — Sales & Marketing
$1M+400%
McKesson logo
MCKPrescription Technology Solutions — Revenue derived from services (less than) (as a percent)
7%0.0pp
Bausch Health Companies logo
BHCProduct sales — Revenue
$2.5B+12.3%
Albertsons Companies logo
ACIPharmacy — Net sales and other revenue
$2.69B+18.9%
NeoGenomics logo
NEOReportable Segment — Sales and marketing
$23.48M+8.1%

Other financials

Income statement

See full
Revenue$194.0M-4.4%
Gross profit$173.9M-8.3%
Operating income$14.0M-40.1%
Net income$1.2M-89.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$235.7M-21.7%
Total debt$541.4M0.0%
Total equity$622.0M-4.9%
Total assets$2.0B+56.0%

Cash flow

See full
Operating cash flow$11.8M+25.8%
CapEx$1.1M+700%
Free cash flow$10.7M+15.4%

Valuation

See full
Market cap$934.74M-44.5%
Enterprise value$1.24B-35.4%
P/E45.5×-13.8×
P/S1.2×-0.9×

Profitability

See full
Gross margin91.8%-2.0pp
Operating margin9.9%-0.3pp
Net margin2.6%-1.0pp
FCF margin21%+2.3pp

Returns & leverage

See full
Return on equity3.2%-1.2pp
Debt / equity0.9×0.0×
Current ratio1.5×-3.8×

Where this comes from

Reported directly by GoodRx Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The official record: GoodRx Holdings, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s prescription transactions revenue — sales and marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s prescription transactions revenue — sales and marketing?
GoodRx Holdings, Inc. (GDRX) reported prescription transactions revenue — sales and marketing of $0 in Q4 2025.
What is the long-term trend for GoodRx Holdings, Inc.'s prescription transactions revenue — sales and marketing?
Over 3 years (2022 to 2025), GoodRx Holdings, Inc.'s prescription transactions revenue — sales and marketing has grown at a -100.0% compound annual growth rate (CAGR), from $24.7M to $0.
What does prescription transactions revenue — sales and marketing mean?
This metric represents the expenditures dedicated to advertising, brand promotion, and customer acquisition efforts specifically aimed at driving volume for the prescription transactions segment. It reflects the company's investment strategy to grow its user base and increase transaction frequency within the digital healthcare platform. Analyzing this spend relative to revenue growth helps evaluate the return on investment for marketing initiatives and the sustainability of customer acquisition costs.